Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWag Payment Regulatory News (WPS)

  • There is currently no data for WPS

Director/PDMR Shareholding

14 Oct 2021 17:33

RNS Number : 1522P
Eurowag
14 October 2021
 

 W.A.G payment solutions plc

14 October 2021

W.A.G payment solutions plc

Notification and public disclosure of transactions by PDMRS

Grant of Performance Share Plan Awards ("PSA")

W.A.G payment solutions plc (the "Company") announces that on 13 October 2021 the following awards over ordinary shares of 1 pence each in the Company were granted under the W.A.G payment solutions plc Performance Share Plan to the following person(s) discharging managerial responsibilities:

Participant

Position

No. of Shares under Award

 Award Type

Magdalena Bartoś

Chief Financial Officer

333,333

Normal PSA

Magdalena Bartoś

Chief Financial Officer

683,760

Additional PSA

The Normal PSAs noted above were granted as options with an option price per share of 1 pence and will ordinarily vest on the third anniversary of their grant date, subject to the grantee's continued service and the Remuneration Committee's assessment of the extent to which the award's performance conditions are satisfied. A post vesting holding period applies to the Normal PSA granted to the CFO during which vested shares (net of sales for tax) must ordinarily be retained until the second anniversary of the vesting of her award.

The Normal PSAs are subject to sliding scale adjusted EBITDA performance targets (which will be re-expressed as adjusted EBITDA per share) for the financial year ending 31 December 2023. The targets require significant growth on 2020 EBITDA.

The Additional PSAs noted above were also granted as options with an option price per share of 1 pence and will ordinarily vest on 1 April 2023 in the case of the CFO and 1 October 2023 in the case of the CSO, subject to the grantee's continued service and the Remuneration Committee's assessment of the extent to which the award's performance conditions are satisfied. A post vesting holding period applies to the Additional PSAs during which vested shares (net of sales for tax) must ordinarily be retained until the second anniversary of the vesting of the relevant award.

The Additional PSAs are subject to sliding scale adjusted EBITDA performance targets (which will be re-expressed as adjusted EBITDA per share) for the financial year ending 31 December 2022. The targets require significant growth on 2020 EBITDA.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Magdalena Bartoś

 

2

Reason for Notification

a)

Position/status

Chief Financial Officer

 

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

W.A.G payment solutions plc

b)

LEI

213800HU63CWV5J8YK95

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1 pence each in W.A.G payment solutions plc

GB00BLGXWY71

 

b)

Nature of the transaction

Grant of options over ordinary shares under the W.A.G payment solutions plc Performance Share Plan with an option price of 1 pence per share.

 

 

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

1. Nil

2. Nil

1. 333,333

2. 683,760

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

e)

Date of the transaction

13 October 2021

f)

Place of the transaction

Outside of a trading venue

 

 

Enquiries: 

Tomáš Novotný

Head of Investor Relations

investors@eurowag.com

W.A.G payment solutions plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFIFMLEFSESS
Date   Source Headline
4th Sep 20257:00 amRNS2025 Interim Results
4th Sep 20257:00 amRNSChange of ticker symbol to ‘EWG’
4th Sep 20257:00 amRNSResult of Meeting - CORRECTION
3rd Sep 20256:00 pmRNSResult of Meeting
2nd Sep 20251:00 pmRNSDoc re. Investor Presentation
6th Aug 20252:00 pmRNSNotice of GM
30th Jun 202510:00 amRNSTotal Voting Rights
22nd May 20255:10 pmRNSResult of AGM
14th May 20253:00 pmRNSDirector Declaration
1st May 202512:00 pmRNSBlock listing Interim Review
16th Apr 20253:00 pmRNSDirector/PDMR Shareholding
9th Apr 202511:55 amRNSAnnual Financial Report
25th Mar 20257:00 amRNSPreliminary results for the year ended 31 Dec 2024
28th Feb 202512:00 pmRNSTotal Voting Rights
21st Feb 202512:00 pmRNSDirectorate Change
21st Jan 20257:01 amRNSBoard changes
21st Jan 20257:00 amRNSTrading Update
10th Jan 20259:00 amRNSAppointment of joint broker
31st Dec 202412:00 pmRNSTotal Voting Rights
29th Nov 202412:00 pmRNSTotal Voting Rights
31st Oct 202410:00 amRNSDoc re. Block Listing Application
24th Oct 20247:00 amRNSTrading Update
5th Sep 20247:00 amRNSW.A.G payment solutions plc Interim results 2024
3rd Jun 202410:19 amRNSCompany Secretary Change
17th May 202412:45 pmRNSDirector/PDMR Shareholding
16th May 20245:39 pmRNSResult of AGM
25th Apr 20247:00 amRNSTrading Update
25th Apr 20247:00 amRNSFireTMS restructuring option
24th Apr 20241:43 pmRNSDirector/PDMR Shareholding
18th Apr 202410:38 amRNSExercise of Options, Issue of Equity and TVR
11th Apr 202411:25 amRNSNotice of AGM
26th Mar 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
20th Feb 20243:48 pmRNSTermination of SPA for additional stake in JITpay
7th Feb 20242:35 pmRNSBoard Changes
18th Jan 20247:00 amRNSTrading Update
26th Oct 20232:48 pmRNSStatement re Shareholder Engagement
24th Oct 20237:00 amRNSTrading Update
11th Oct 20237:00 amRNSCapital Markets Day
7th Sep 20237:00 amRNSHalf-year Report
1st Sep 20231:52 pmRNSTotal Voting Rights
4th Jul 202310:59 amRNSDirector Declaration
4th Jul 20237:02 amRNSCall option to acquire JITpay
12th May 20239:11 amRNSDirector/PDMR Shareholding
11th May 20235:51 pmRNSResult of AGM
3rd May 202311:01 amRNSDirector Declaration
25th Apr 20233:45 pmRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSDirectorate Changes and AGM Update
25th Apr 20237:00 amRNSTrading Update
12th Apr 20235:53 pmRNSNotice of AGM 2023
21st Mar 20237:30 amRNSAnnual Report 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.